RU2742828C2 - Применение стволовых клеток, экспрессирующих мезенхимальные и нейрональные маркеры, и их композиций для лечения неврологических заболеваний (варианты) - Google Patents

Применение стволовых клеток, экспрессирующих мезенхимальные и нейрональные маркеры, и их композиций для лечения неврологических заболеваний (варианты) Download PDF

Info

Publication number
RU2742828C2
RU2742828C2 RU2018134615A RU2018134615A RU2742828C2 RU 2742828 C2 RU2742828 C2 RU 2742828C2 RU 2018134615 A RU2018134615 A RU 2018134615A RU 2018134615 A RU2018134615 A RU 2018134615A RU 2742828 C2 RU2742828 C2 RU 2742828C2
Authority
RU
Russia
Prior art keywords
hidpsc
cells
disease
stem cells
subject
Prior art date
Application number
RU2018134615A
Other languages
English (en)
Russian (ru)
Other versions
RU2018134615A3 (https=
RU2018134615A (ru
Inventor
Ирина КЕРКИС
Кристиан ВАЛЬВЕРДЕ ВЕНЦЕСЛАУ
Original Assignee
Авита Интернэшнл Лтд.
Фундашао Бутантан
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US15/065,259 external-priority patent/US11207352B2/en
Application filed by Авита Интернэшнл Лтд., Фундашао Бутантан filed Critical Авита Интернэшнл Лтд.
Publication of RU2018134615A publication Critical patent/RU2018134615A/ru
Publication of RU2018134615A3 publication Critical patent/RU2018134615A3/ru
Application granted granted Critical
Publication of RU2742828C2 publication Critical patent/RU2742828C2/ru

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/32—Bones; Osteocytes; Osteoblasts; Tendons; Tenocytes; Teeth; Odontoblasts; Cartilage; Chondrocytes; Synovial membrane
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/177—Receptors; Cell surface antigens; Cell surface determinants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
    • C12N5/0662—Stem cells
    • C12N5/0664—Dental pulp stem cells, Dental follicle stem cells

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Neurology (AREA)
  • Immunology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Neurosurgery (AREA)
  • Cell Biology (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Epidemiology (AREA)
  • Rheumatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Virology (AREA)
  • Pain & Pain Management (AREA)
  • Ophthalmology & Optometry (AREA)
  • Transplantation (AREA)
  • Dermatology (AREA)
  • Psychiatry (AREA)
  • Psychology (AREA)
  • Cardiology (AREA)
  • Physical Education & Sports Medicine (AREA)
RU2018134615A 2016-03-09 2017-03-09 Применение стволовых клеток, экспрессирующих мезенхимальные и нейрональные маркеры, и их композиций для лечения неврологических заболеваний (варианты) RU2742828C2 (ru)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US15/065,259 2016-03-09
US15/065,259 US11207352B2 (en) 2013-03-15 2016-03-09 Compositions comprising stem cells expressing mesenchymal and neuronal markers and uses thereof to treat neurological disease
PCT/IB2017/051404 WO2017153956A1 (en) 2016-03-09 2017-03-09 Uses of dental pulp stem cells expressing mesenchymal and neuronal markers and compositions thereof to treat neurological disease

Publications (3)

Publication Number Publication Date
RU2018134615A RU2018134615A (ru) 2020-04-10
RU2018134615A3 RU2018134615A3 (https=) 2020-07-28
RU2742828C2 true RU2742828C2 (ru) 2021-02-11

Family

ID=58387859

Family Applications (2)

Application Number Title Priority Date Filing Date
RU2018134615A RU2742828C2 (ru) 2016-03-09 2017-03-09 Применение стволовых клеток, экспрессирующих мезенхимальные и нейрональные маркеры, и их композиций для лечения неврологических заболеваний (варианты)
RU2018134710A RU2741839C2 (ru) 2016-03-09 2017-03-09 Стволовые клетки, экспрессирующие мезенхимальные и нейрональные маркеры, их композиции и способы их получения

Family Applications After (1)

Application Number Title Priority Date Filing Date
RU2018134710A RU2741839C2 (ru) 2016-03-09 2017-03-09 Стволовые клетки, экспрессирующие мезенхимальные и нейрональные маркеры, их композиции и способы их получения

Country Status (8)

Country Link
EP (2) EP3426770A1 (https=)
JP (2) JP6997716B2 (https=)
KR (2) KR102497999B1 (https=)
CN (2) CN109219441B (https=)
CA (1) CA3055398A1 (https=)
IL (2) IL261622B2 (https=)
RU (2) RU2742828C2 (https=)
WO (2) WO2017153956A1 (https=)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109152801A (zh) * 2016-05-16 2019-01-04 国立大学法人名古屋大学 采用多能干细胞的围产期脑损伤的改善及治疗
US11547730B2 (en) 2017-05-26 2023-01-10 Steminent Biotherapeutics Inc. Therapy for polyglutamine (polyQ) diseases
KR20210041578A (ko) * 2018-07-31 2021-04-15 제이씨알 파마 가부시키가이샤 치수 유래 세포의 제조 방법
DK3894857T3 (da) * 2019-04-15 2022-11-07 Nanologica Ab Tomme porøse partikler til anvendelse ved behandling, forebyggelse og/eller udskydelse af degeneration af neurodegenerative sygdomme, neuroner og glia
CN110179827A (zh) * 2019-06-27 2019-08-30 北京三有利和泽生物科技有限公司 牙源性间充质干细胞的应用
CN110314172A (zh) * 2019-07-17 2019-10-11 中国医科大学附属第一医院 一种用于治疗脊髓损伤的细胞制剂及其制备方法
JPWO2021200744A1 (https=) * 2020-03-31 2021-10-07
CN111973631A (zh) * 2020-08-21 2020-11-24 卡替(上海)生物技术有限公司 牙髓间充质干细胞在制备阿尔茨海默病治疗药物中的用途
CN115192609A (zh) * 2022-05-10 2022-10-18 湖南中南大学湘雅口腔医院 间充质干细胞在制备治疗抑郁症的药物中的应用
WO2025084896A1 (ko) * 2023-10-18 2025-04-24 연세대학교 산학협력단 신경세포 분화 유도용 재조합 벡터 및 이를 포함하는 퇴행성 뇌신경 질환의 예방 또는 치료용 약학적 조성물

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2347579C1 (ru) * 2007-07-03 2009-02-27 Общество с ограниченной ответственностью "Медицинские технологии" Способ получения клеточной культуры для лечения сосудистых и демиелинизирующих заболеваний нервной системы и клеточная культура, полученная этим способом (варианты)
US20110158962A1 (en) * 2008-06-26 2011-06-30 Federico Ferro Dental pulp marrow similar cells (dpmsc) and methods of isolating and using
US20150050248A1 (en) * 2013-03-15 2015-02-19 Avita International Ltd. Multifunctional immature dental pulp stem cells and therapeutic applications

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2465924A3 (en) 2005-06-16 2013-01-02 Ramot at Tel-Aviv University Ltd. Isolated cells and populations comprising same for the treament of cns diseases
WO2008080200A1 (en) * 2006-12-29 2008-07-10 Irina Kerkis Process for obtaining stem cells
CN101668848B (zh) 2007-04-26 2014-10-22 雷蒙特亚特特拉维夫大学有限公司 来自口腔粘膜的多能自体干细胞和使用方法
JP5408578B2 (ja) * 2007-12-05 2014-02-05 国立大学法人名古屋大学 歯髄幹細胞を用いた自家又は同種移植用組成物及びその用途
EP2263706B1 (en) * 2008-03-12 2017-11-15 National Center for Geriatrics and Gerontology Root canal filler and dental tissue regeneration method
EP2620493B1 (en) 2008-05-28 2019-03-27 Ramot at Tel Aviv University Ltd. Mesenchymal stem cells for the treatment of CNS diseases
CN102725398B (zh) * 2009-12-21 2014-01-08 学校法人总持学园鹤见大学 用于培养及保存牙髓细胞的离体牙的移送方法
WO2012117373A1 (en) 2011-03-03 2012-09-07 Ramot At Tel-Aviv University Ltd. Genetically modified muscle cells which express neurotrophic factors
WO2013076726A1 (en) 2011-11-21 2013-05-30 Ramot At Tel-Aviv University Ltd. Stem cell-derived neural cells for cell therapy in neurological disorders
EP2633870B1 (en) * 2012-02-29 2018-08-01 Technische Universität Berlin Method of preparing an artificial tooth primordium in vitro and artificial tooth primordium derived therefrom

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2347579C1 (ru) * 2007-07-03 2009-02-27 Общество с ограниченной ответственностью "Медицинские технологии" Способ получения клеточной культуры для лечения сосудистых и демиелинизирующих заболеваний нервной системы и клеточная культура, полученная этим способом (варианты)
US20110158962A1 (en) * 2008-06-26 2011-06-30 Federico Ferro Dental pulp marrow similar cells (dpmsc) and methods of isolating and using
US20150050248A1 (en) * 2013-03-15 2015-02-19 Avita International Ltd. Multifunctional immature dental pulp stem cells and therapeutic applications

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
SAKAI K., et al. "Human dental pulp-derived stem cells promote locomotor recovery after complete transection of the rat spinal cord by multiple neuro-regenerative mechanisms", JCI. 2012; 122(1):80-90; DOI: 10.1172/JCI59251. *

Also Published As

Publication number Publication date
CA3055398A1 (en) 2017-09-14
CN109219441A (zh) 2019-01-15
CA3055399A1 (en) 2017-09-14
RU2018134615A3 (https=) 2020-07-28
RU2018134710A (ru) 2020-04-09
JP2019507772A (ja) 2019-03-22
JP2019510758A (ja) 2019-04-18
IL261623A (en) 2018-10-31
EP3426770A1 (en) 2019-01-16
WO2017153957A9 (en) 2017-11-02
RU2018134710A3 (https=) 2020-06-25
JP6997716B2 (ja) 2022-02-04
BR112018067969A2 (pt) 2019-01-15
CN109312303B (zh) 2024-03-26
WO2017153957A1 (en) 2017-09-14
CN109219441B (zh) 2022-06-10
EP3426267B1 (en) 2023-01-11
RU2741839C2 (ru) 2021-01-29
RU2018134615A (ru) 2020-04-10
BR112018067971A2 (pt) 2019-01-15
CN109312303A (zh) 2019-02-05
IL261622B2 (en) 2023-09-01
KR102497999B1 (ko) 2023-02-08
WO2017153956A1 (en) 2017-09-14
IL261623B1 (en) 2023-11-01
EP3426267A1 (en) 2019-01-16
IL261622A (en) 2018-10-31
IL261622B1 (en) 2023-05-01
IL261623B2 (en) 2024-03-01
KR20180137488A (ko) 2018-12-27
KR102363146B1 (ko) 2022-02-14
KR20190003489A (ko) 2019-01-09
JP7008031B2 (ja) 2022-02-10

Similar Documents

Publication Publication Date Title
RU2742828C2 (ru) Применение стволовых клеток, экспрессирующих мезенхимальные и нейрональные маркеры, и их композиций для лечения неврологических заболеваний (варианты)
AU2023200036B2 (en) Assessing retinal pigment epithelial cell populations
US20250295700A1 (en) Use of stem cells expressing mesenchymal and neuronal markers and compositions thereof to treat neurological disease
US20240245727A1 (en) Compositions comprising stem cells expressing mesenchymal and neuronal markers and uses thereof to treat neurological disease
KR101895648B1 (ko) 치수줄기세포를 포함하는 신경질환 치료용 약학 조성물 및 이의 제조방법
US11306290B2 (en) Stem cells expressing mesenchymal and neuronal markers, compositions thereof, and methods of preparation thereof
CA3055399C (en) Stem cells expressing mesenchymal and neuronal markers, compositions thereof, and methods of preparation thereof
HK40001515B (zh) 表达间充质和神经元标志物的干细胞、其组合物及其制备方法
HK40001515A (en) Stem cells expressing mesenchymal and neuronal markers, compositions thereof, and methods of preparation thereof
HK40001297A (en) Uses of dental pulp stem cells expressing mesenchymal and neuronal markers and compositions thereof to treat neurological disease
HK40001297B (en) Uses of dental pulp stem cells expressing mesenchymal and neuronal markers and compositions thereof to treat neurological disease
BR112018067971B1 (pt) Método para produzir células estaminais de polpa dentária imaturas humanas
BR112018067969B1 (pt) Uso de células estaminais de polpa dentária que expressam marcadores neuronais mesenquimais e composições das mesmas para tratar doença neurológica
WO2007138577A2 (en) Methods of generating a neural tissue using muscle-derived cells
Mead Mesenchymal stem cell therapy for traumatic and degenerative eye disease
NZ733006A (en) Rpe cell populations and methods of generating same